Dianthus Therapeutics Inc... (DNTH)
21.38
0.28 (1.33%)
At close: Jan 28, 2025, 2:57 PM
Ratios (Annual)
Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 |
| PE Ratio | -1.23 | -0.83 | -18.57 | -4.6 | -7.31 | -1.82 | -14.47 | -54.46 |
| PS Ratio | 18.97 | 3.69 | 164.92 | n/a | n/a | n/a | n/a | n/a |
| PB Ratio | 0.32 | -0.53 | -14.11 | 2.39 | 3.97 | 0.72 | 10.21 | 56.80 |
| P/FCF Ratio | -1.45 | -0.81 | -24.5 | -5.34 | -9.33 | -2.12 | -20.99 | -77.02 |
| P/OCF Ratio | -1.45 | -0.81 | -24.58 | -5.38 | -9.83 | -2.5 | -23.07 | -78.66 |
| OCF/S Ratio | -13.04 | -4.53 | -6.71 | n/a | n/a | n/a | n/a | n/a |
| Debt / Equity Ratio | 0.00 | -0.02 | n/a | n/a | n/a | n/a | n/a | n/a |
| Quick Ratio | 18.42 | 9.87 | 1.70 | 13.26 | 10.62 | 13.95 | 12.68 | 4.71 |
| Current Ratio | 18.42 | 9.97 | 1.75 | 13.26 | 10.62 | 13.95 | 12.68 | 4.71 |
| Asset Turnover | 0.02 | 0.08 | 0.16 | n/a | n/a | n/a | n/a | n/a |
| Interest Coverage | n/a | n/a | -3.68 | -20.9 | n/a | n/a | n/a | -56.86 |
| Return on Equity (ROE) | -0.26 | 0.64 | 0.76 | -0.52 | -0.54 | -0.39 | -0.71 | -1.04 |
| Return on Assets (ROA) | -0.24 | -0.34 | -1.39 | -0.46 | -0.48 | -0.37 | -0.65 | -0.83 |
| Return on Capital (ROIC) | -0.28 | -0.4 | -3.19 | -0.52 | -0.56 | -0.41 | -0.71 | -1.02 |
| Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Gross Profit Margin | 87.44% | 97.71% | -36.86% | n/a | n/a | n/a | n/a | n/a |
| Net Profit Margin | -1.54K% | -443.76% | -888.14% | n/a | n/a | n/a | n/a | n/a |
| Pretax Profit Margin | -1.54K% | -443.76% | -888.14% | n/a | n/a | n/a | n/a | n/a |
| Operating Profit Margin | -1.70K% | -462.91% | -886.59% | n/a | n/a | n/a | n/a | n/a |
| FCF Margin | -1.31K% | -455.18% | -673.24% | n/a | n/a | n/a | n/a | n/a |
| EBITDA Margin | -1.70K% | -460.62% | -886.59% | n/a | n/a | n/a | n/a | n/a |